scholarly journals How Far Has theInternational Neurourology JournalProgressed Since Its Transformation Into an English Language Journal?

2014 ◽  
Vol 18 (1) ◽  
pp. 3 ◽  
Author(s):  
Sun Huh
2019 ◽  
Vol 23 (5) ◽  
pp. 116-121
Author(s):  
A. I. Nevorotin ◽  
I. V. Awsiewitsch ◽  
I. M. Sukhanov

This article is the continuation of analysis and discussion from the book by Professor AI Nevorotin "Matrix phraseological collection: a manual for writing a scientific article in English". The Matrix phraseological collection is a kind of catalog of text samples. The samples were from articles selected from the leading English-language scientific journals and were systematized in such away that when writing an article in English, a Russian researchers are able easy to find examples suitable for his/her own work. Furthermore, the selected samples can be transformed accordingly saving the semantic and syntactic relations between the elements and, finally, be inserted into the text. The second part of this work is devoted to the detailed analysis of the English scientific literature and also the section "Legality of the provisions of the problem".


PEDIATRICS ◽  
1973 ◽  
Vol 51 (6) ◽  
pp. 1037-1041
Author(s):  
Eugene Blank ◽  
Alvin Chisolm

A 27-year-old woman had congenital microgastria, which was apparent in roentgenographic examination when she was 1 year of age. Despite inability to eat anything but pureed foods for the first 13 years and despite persistent vomiting during that time, she has reached normal adult size and has three healthy children. This report represents two firsts: the first case of congenital microgastria in an English language journal of pediatrics and the first with a long follow-up.


1993 ◽  
Vol 27 (9) ◽  
pp. 1090-1098 ◽  
Author(s):  
Patricia Flores-Runk ◽  
Ralph H. Raasch

OBJECTIVE: To review the pharmacology, pharmacokinetics, clinical efficacy, and toxicity of ticlopidine. Comparisons with other antiplatelet agents are presented, with an emphasis on efficacy, and a recommendation is provided regarding ticlopidine's place in therapy. DATA SOURCES: A MEDLINE literature retrieval of English-language journal articles from 1987 to January 1993 and references identified from bibliographies of review articles and clinical trials. STUDY SELECTION: Randomized, blind, controlled studies of ticlopidine and other antiplatelet agents were preferentially selected. DATA EXTRACTION: Clinical trials were reviewed in terms of study design, efficacy results, and toxicity. DATA SYNTHESIS: Ticlopidine is a new antiplatelet agent with a distinct mechanism of action. In the largest trial of the drug for the prevention of stroke, it was found to be more effective than aspirin in reducing the risk of stroke or death. Clinical trials have also shown ticlopidine to decrease the rate of vascular death and myocardial infarction in patients with unstable angina, and to maintain venous graft patency after coronary artery bypass grafting. The use of ticlopidine in diabetic microangiopathy and peripheral vascular disease appears promising, but further studies are needed. Adverse reactions most commonly reported with ticlopidine are gastrointestinal complaints; the most severe reaction is transient neutropenia, which is seen in approximately 2.3 percent of patients and is severe in nearly 1 percent. CONCLUSIONS: Ticlopidine is a reasonable alternative for use in preventing stroke among patients unable to take aspirin or those who do not benefit from aspirin therapy. Its use as first-line therapy is limited by its high cost and the occurrence of hematologic adverse effects.


2019 ◽  
Vol 31 (1) ◽  
pp. 8-8
Author(s):  
Yoshihiro Takita ◽  

Congratulations to the Journal of Robotics and Mechatronics (JRM) on its 30th anniversary. I would like to thank all authors and readers who have contributed to the JRM through 30 years. The JRM started as an English-language journal published to provide articles on robot technologies to the world from Japan. It has been jointly edited by the Robotics and Mechatronics Division (RMD) of the Japan Society of Mechanical Engineers (JSME) and Fuji Technology Press Ltd. Five years ago, when the English-language journal of the JSME was reorganized, the JRM also underwent some changes, and it has since been issued under the editorial direction of Fuji Technology Press Ltd. Immediately after the reorganization, beginning with Vol.26, I was appointed Editor-in-Chief. Now, as five years have passed, the next Editor-in-Chief will take over from Vol.31. Over these five years, the number of submissions and their quality have been our major concern, as we have been seeking to register the JRM with the Science Citation Index (SCI). To achieve this goal, we have published special issues on the robot technologies required as the field has progressed as well as on the mechatronics technologies that underlie them. The JRM plans to continue providing the world with information on robot technologies, so please keep reading it and submitting your articles to it on a regular basis. Yoshihiro Takita


2009 ◽  
Vol 200 ◽  
pp. 895-896
Author(s):  
David C. Wilson

When I took over as the second editor, resigning from the British Diplomatic Service to do so and as an opportunity to work in my spare time on a PhD relating to modern China, The China Quarterly had already established itself as the leading English-language journal on contemporary China under its founder-editor, Rod MacFarquhar. Rod had done a superb job as the first editor and was moving on to play a role in British political life as a Member of Parliament and from thence to Harvard and academic distinction. The China Quarterly too was moving, from its earlier position as one of a group of journals funded by the International Association for Cultural Freedom, to coming under the wing of the newly established Contemporary China Institute at the School of Oriental and African Studies (SOAS) in London. There, that great scholar on the life and political thought of Mao Zedong, Stuart Schram, had just been appointed Director.


2017 ◽  
Author(s):  
Masahiro Suzuki ◽  
Chen-Fu Pai ◽  
Md. Jahirul Islam

Empirical work on criminological theories in Asia has been increasing. However, few comprehensive and systematic reviews on the application of criminological theories in Asia have been conducted. Using a systematic quantitative literature review method on peer-reviewed English-language journal articles, we aim to provide an overview of the use of five major criminological theories in Asia: (1) strain; (2) social learning; (3) control; (4) routine activity; and (5) developmental and life-course. In particular, we address the following four questions: (1) how often are these theories tested in which region of Asia?; (2) what methodology is used to test these theories?; (3) to what extent are these theories supported in the Asian context?; and (4) what cultural uniqueness in the Asian context is taken into account in testing these theories, and what role and effect do they play in analysis and outcome? Findings indicate that the relationship between these theories and the Asian regions is skewed; many studies do not employ rigorous methodologies; these theories are either fully or partially supported in the Asian context; and only a few studies have analyzed the cultural uniqueness of the Asian context, and no effect of cultural uniqueness of the Asian context was found. Research implications for developing criminology in Asia are discussed.


1997 ◽  
Vol 13 (6) ◽  
pp. 248-251
Author(s):  
Jennifer H Tran ◽  
John D Seeger

Objective: To review the literature discussing the use of two-step tuberculin skin testing for hospital employees. Data Sources: English-language journal articles involving human subjects. Study Selection: Selected articles describing the use of two-step tuberculin skin testing. Data Extraction: Information relevant to the topic was extracted from the articles and synthesized into this report. Data Synthesis: People infected with tuberculosis exhibit a skin-test reaction to tuberculin, but this reaction can diminish over time. A two-step tuberculin skin test involves the administration of a second injection of tuberculin 1–3 weeks after the initial injection. The rationale for the use of the two-step tuberculin skin test is to help differentiate between individuals with new tuberculosis infections and those with previous infections whose immune response to tuberculin had decreased to levels not detectable with a single skin test. Conclusions: Two-step tuberculin skin testing is effective at detecting a booster effect. Despite the recent mandate by the Occupational Safety and Health Administration to use two-step tuberculin testing in all healthcare facilities, such testing may not be cost-effective in institutions with young employees, high employee turnover, and a low risk of tuberculosis. The requirements for universal two-step tuberculin testing may need to be reevaluated to account for these factors.


1992 ◽  
Vol 26 (4) ◽  
pp. 510-514 ◽  
Author(s):  
Michele F. Shepherd ◽  
Kathleen D. Lake ◽  
Melissa A. Kamps

OBJECTIVE: To review the mechanisms and sequence of events that occur during ischemia and cell death and following death of the human body. The impact of these postmortem events on the distribution and pharmacokinetic behavior of drugs is described. The case study presented illustrates a possible situation where such postmortem changes could have affected the pharmacokinetics of procainamide. DATA SOURCES: English-language journal articles and reference texts identified from pertinent data sources. DATA SYNTHESIS: Postmortem changes in the human body begin at the cellular level with the onset of ischemia. As the length of time of ischemia increases and death ensues, more changes occur and lead to deterioration in tissue and organ function. These changes may affect the pharmacokinetic and distribution behavior of certain drugs. Drugs particularly affected are those whose distribution is dependent on molecular size, lipophilicity, pH, energy-dependent transport, and tissue binding. Such drugs include the tricyclic antidepressants, digoxin, and cimetidine. Other drugs with similar characteristics, such as procainamide, may also demonstrate like changes in distribution and pharmacokinetics. CONCLUSIONS: When measuring drug concentrations after death, it is important to consider the phenomenon of postmortem redistribution. Postmortem drug concentrations may not be a true reflection of antemortem concentrations and as a result, wrong conclusions could be made about the cause of death. More studies characterizing the postmortem distribution and pharmacokinetic characteristics of specific drugs are necessary.


1992 ◽  
Vol 26 (12) ◽  
pp. 1566-1575 ◽  
Author(s):  
Kathleen D. Lake ◽  
Jacqueline G. Nolen ◽  
Ralph A. Slaker ◽  
Thomas J. Reutzel ◽  
Sherry K. Milfred ◽  
...  

OBJECTIVE: The purpose of this article is to review the pathophysiology of the denervated heart and the factors that need to be considered before recommending the use of over-the-counter (OTC) medications in the cardiac transplant recipient. DATA SOURCES: Pharmacology and therapeutic textbooks, English-language journal articles, and physiology textbooks published between 1969 and 1991. DATA EXTRACTION: Case reports, controlled case studies, and textbook chapters evaluating drug interactions with immunosuppressive agents were reviewed. The effects of various OTC medications on the denervated heart were examined and relevant material was extrapolated. DATA ANALYSIS: The number of cases or studies in which a particular effect or interaction occurred was reported. Those findings that were less well documented were either identified as such or were not included in the review. DATA SYNTHESIS: Common pharmacokinetic and pharmacodynamic interactions with the primary immunosuppressive agents (e.g., cyclosporine, azathioprine, prednisone) are reviewed. The physiology and altered responses of the denervated heart to various medications are also explained. Using this information, recommendations are given for the use and monitoring of OTC analgesics, antacids, laxatives, sleep aids, stimulants, and other medications that may be used in the cardiac transplant recipient. CONCLUSIONS: Many OTC medications can be used safely in the cardiac transplant recipient. In each situation, risk/benefit assessments must always be made and therapy should be monitored closely. Most important, patients should always notify the transplant team before adding an OTC product to their immunosuppressive regimen.


Sign in / Sign up

Export Citation Format

Share Document